ArticleBMJ global health2025

Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova.

Kasim Allel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.